Tag:
translational research
Latest Headlines
Latest Headlines
Ex-Genzyme CEO Termeer, GE back translational tech with $20M round
Henri Termeer may have retired from Genzyme after the Sanofi buyout, but he hasn't lost his appetite for betting on promising new technologies for the life sciences field. This morning Seattle-based
NIH launches $140M drug tox project, hunts for translational R&D chief
As the White House helps boost the efforts of NIH chief Francis Collins to create an ambitious new center for translational biomedical research, the agency has struck a deal with the FDA and the
NIH launches $140M drug tox project, hunts for translational R&D chief
As the White House helps boost the efforts of NIH chief Francis Collins to create an ambitious new center for translational biomedical research, the agency has struck a deal with the FDA and the
New drug-discovery center lost in translation
When last we left NIH chief Francis Collins' ambitious plans to build a new center for translational medicine, the project seemed to be "moving at light-speed" by NIH standards, with an October
NIH fast tracks $720M for new drug discovery center
NIH chief Francis Collins made waves in the research community with his ambitious plans to build a new center designed to speed up the high-risk business of chaperoning new drugs out of the lab and
The development revolution starts now--at a university near you
Roche says that it will work with the University of Geneva, Geneva University Hospitals and the Swiss Institute of Bioinformatics in the translational research arena--just the latest example of a big
GSK burnishes its "open innovation" rep with new translational research fund
GlaxoSmithKline helped seal its reputation as one of the leaders in the "open innovation" movement today with its announcement of a new GSK-MaRS Innovation Fund to help accelerate translational work
GSK, AZ join hands to create new center for collaborative drug research
Here's an interesting new twist on all the drug development partnerships now being formed between Big Pharma and academia. Take a university known for top drug research, add two Big Pharmas and get
How pharma can cross the valley and fear no upheaval
FasterCures, a nonprofit think tank affiliated with the Milken Institute, is devoted to accelerating the discovery and development of new medical solutions for diseases. And in a commentary in the
"Frustrated" NIH chief plots $1B drug development effort
Pronouncing himself "a little frustrated" with pharma's apparent inability to rapidly follow up on scientific breakthroughs with a new generation of therapeutics, NIH chief Francis Collins is pushing
